Product NDC: | 0173-0447 |
Proprietary Name: | ZOFRAN |
Non Proprietary Name: | ondansetron hydrochloride |
Active Ingredient(s): | 8 mg/1 & nbsp; ondansetron hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0447 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020103 |
Marketing Category: | NDA |
Start Marketing Date: | 19930211 |
Package NDC: | 0173-0447-00 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0447-00) |
NDC Code | 0173-0447-00 |
Proprietary Name | ZOFRAN |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (0173-0447-00) |
Product NDC | 0173-0447 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ondansetron hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19930211 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |